Michael Polark
Stock Analyst at Wolfe Research
(3.81)
# 1,888
Out of 4,357 analysts
181
Total ratings
50%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Downgraded: Hold | n/a | $48.31 | - | 6 | May 29, 2026 | |
| NYXH Nyxoah | Maintained: Hold | n/a | $2.98 | - | 5 | May 13, 2026 | |
| ABT Abbott Laboratories | Maintained: Hold | n/a | $85.60 | - | 5 | Apr 16, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $92 | $86.47 | +6.40% | 8 | Apr 1, 2026 | |
| INSP Inspire Medical Systems | Downgraded: Hold | n/a | $41.36 | - | 15 | Feb 13, 2026 | |
| MDLN Medline | Initiated Coverage: Buy | $47 | $36.56 | +28.56% | 1 | Jan 12, 2026 | |
| MDT Medtronic | Reiterated: Hold | n/a | $73.81 | - | 6 | Aug 25, 2025 | |
| NPCE NeuroPace | Maintained: Buy | $14 → $13 | $16.54 | -21.40% | 11 | Aug 14, 2025 | |
| STE STERIS | Maintained: Buy | $245 → $270 | $212.73 | +26.92% | 17 | Aug 8, 2025 | |
| SHC Sotera Health Company | Maintained: Buy | $19 → $17 | $15.64 | +8.70% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $12.12 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $73.80 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $144.94 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $21.26 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $190.57 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $305.09 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $82.33 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $113.90 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $137 → $145 | $178.45 | n/a | 16 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.38 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $140 | $73.74 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $128.64 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $17.20 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $424.64 | n/a | 9 | Apr 5, 2022 |
Boston Scientific
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $48.31
Upside: -
Nyxoah
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $2.98
Upside: -
Abbott Laboratories
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $85.60
Upside: -
Edwards Lifesciences
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $86.47
Upside: +6.40%
Inspire Medical Systems
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $41.36
Upside: -
Medline
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $36.56
Upside: +28.56%
Medtronic
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $73.81
Upside: -
NeuroPace
Aug 14, 2025
Maintained: Buy
Price Target: $14 → $13
Current: $16.54
Upside: -21.40%
STERIS
Aug 8, 2025
Maintained: Buy
Price Target: $245 → $270
Current: $212.73
Upside: +26.92%
Sotera Health Company
Aug 8, 2025
Maintained: Buy
Price Target: $19 → $17
Current: $15.64
Upside: +8.70%
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $12.12
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $73.80
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $144.94
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $21.26
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $190.57
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $305.09
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $82.33
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $113.90
Upside: n/a
Feb 2, 2024
Maintained: Buy
Price Target: $137 → $145
Current: $178.45
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.38
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: $121 → $140
Current: $73.74
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $128.64
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $17.20
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $424.64
Upside: n/a